- Home
- ARGX vs RJF Comparison
ARGX vs RJF Comparison
Compare ARGX & RJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- RJF
- Stock Information
- Founded
- ARGX 2008
- RJF 1962
- Country
- ARGX Netherlands
- RJF United States
- Employees
- ARGX N/A
- RJF N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- RJF Investment Bankers/Brokers/Service
- Sector
- ARGX Health Care
- RJF Finance
- Exchange
- ARGX Nasdaq
- RJF Nasdaq
- Market Cap
- ARGX 35.2B
- RJF 33.8B
- IPO Year
- ARGX 2017
- RJF N/A
- Fundamental
- Price
- ARGX $605.92
- RJF $165.15
- Analyst Decision
- ARGX Strong Buy
- RJF Hold
- Analyst Count
- ARGX 21
- RJF 13
- Target Price
- ARGX $619.79
- RJF $138.58
- AVG Volume (30 Days)
- ARGX 336.7K
- RJF 1.1M
- Earning Date
- ARGX 10-31-2024
- RJF 10-23-2024
- Dividend Yield
- ARGX N/A
- RJF 1.09%
- EPS Growth
- ARGX N/A
- RJF 21.71
- EPS
- ARGX N/A
- RJF 9.70
- Revenue
- ARGX $1,908,659,000.00
- RJF $12,776,000,000.00
- Revenue This Year
- ARGX $61.99
- RJF $11.44
- Revenue Next Year
- ARGX $42.48
- RJF $6.51
- P/E Ratio
- ARGX N/A
- RJF $17.03
- Revenue Growth
- ARGX 85.56
- RJF 11.00
- 52 Week Low
- ARGX $327.73
- RJF $102.42
- 52 Week High
- ARGX $611.22
- RJF $165.42
- Technical
- Relative Strength Index (RSI)
- ARGX 62.35
- RJF 73.37
- Support Level
- ARGX $558.15
- RJF $160.53
- Resistance Level
- ARGX $603.23
- RJF $164.33
- Average True Range (ATR)
- ARGX 12.95
- RJF 3.04
- MACD
- ARGX -0.41
- RJF -0.23
- Stochastic Oscillator
- ARGX 90.01
- RJF 98.83
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About RJF Raymond James Financial Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company supports more than 8,000 employee and independent contractor financial advisors across the United States, Canada, and the United Kingdom with over $1.2 trillion of assets under administration as of September 2023. Approximately 90% of the company's revenue is from the US and 70% is from the company's wealth-management segment.